These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 21111946)

  • 1. Survival of cancer patients with prior monoclonal gammopathy of undetermined significance.
    Gregersen H; Sørensen HT; Engebjerg MC; Jensen P; Severinsen MT; Nørgaard M
    Eur J Intern Med; 2010 Dec; 21(6):564-8. PubMed ID: 21111946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Diagnosis and Clinical Follow-up of Monoclonal Gammopathy of Undetermined Significance on Survival in Multiple Myeloma.
    Sigurdardottir EE; Turesson I; Lund SH; Lindqvist EK; Mailankody S; Korde N; Björkholm M; Landgren O; Kristinsson SY
    JAMA Oncol; 2015 May; 1(2):168-74. PubMed ID: 26181017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    Kyle RA; Rajkumar SV
    Hematol Oncol Clin North Am; 2007 Dec; 21(6):1093-113, ix. PubMed ID: 17996590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Multiple myeloma--diagnosis, prognostic factors and treatment].
    Kitani T
    Rinsho Ketsueki; 1995 May; 36(5):471-9. PubMed ID: 7783353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Monoclonal gammopathy of undetermined significance].
    Chaïbi P; Merlin L; Thomas C; Piette F
    Ann Med Interne (Paris); 2002 Nov; 153(7):459-66. PubMed ID: 12598832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal gammopathy of undetermined significance and multiple myeloma are associated with an increased incidence of venothromboembolic disease.
    Srkalovic G; Cameron MG; Rybicki L; Deitcher SR; Kattke-Marchant K; Hussein MA
    Cancer; 2004 Aug; 101(3):558-66. PubMed ID: 15274069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. History of autoimmune disease is associated with impaired survival in multiple myeloma and monoclonal gammopathy of undetermined significance: a population-based study.
    Lindqvist EK; Landgren O; Lund SH; Turesson I; Hultcrantz M; Goldin L; Björkholm M; Kristinsson SY
    Ann Hematol; 2017 Feb; 96(2):261-269. PubMed ID: 27807648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal gammopathy of undetermined significance and risk of venous thromboembolism.
    Gregersen H; Nørgaard M; Severinsen MT; Engebjerg MC; Jensen P; Sørensen HT
    Eur J Haematol; 2011 Feb; 86(2):129-34. PubMed ID: 20942842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors in monoclonal gammopathy of undetermined significance.
    Sackmann F; Pavlovsky MA; Corrado C; Pizzolato M; Alejandre M; Pavlovsky S
    Haematologica; 2008 Jan; 93(1):153-4. PubMed ID: 18166806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fracture risk in monoclonal gammopathy of undetermined significance.
    Melton LJ; Rajkumar SV; Khosla S; Achenbach SJ; Oberg AL; Kyle RA
    J Bone Miner Res; 2004 Jan; 19(1):25-30. PubMed ID: 14753733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytogenetic patterns in multiple myeloma after a phase of preceding MGUS.
    Kaufmann H; Ackermann J; Odelga V; Sagaster V; Nösslinger T; Pfeilstöcker M; Keck A; Ludwig H; Gisslinger H; Drach J
    Eur J Clin Invest; 2008 Jan; 38(1):53-60. PubMed ID: 18173551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of progression in smouldering myeloma and monoclonal gammopathies of unknown significance: comparative analysis of the evolution of monoclonal component and multiparameter flow cytometry of bone marrow plasma cells.
    Pérez-Persona E; Mateo G; García-Sanz R; Mateos MV; de Las Heras N; de Coca AG; Hernández JM; Galende J; Martín-Nuñez G; Bárez A; Alonso JM; Martín A; López-Berges C; Orfao A; San Miguel JF; Vidriales MB
    Br J Haematol; 2010 Jan; 148(1):110-4. PubMed ID: 19821821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determining the clinical significance of monoclonal gammopathy of undetermined significance: a SEER-Medicare population analysis.
    Go RS; Gundrum JD; Neuner JM
    Clin Lymphoma Myeloma Leuk; 2015 Mar; 15(3):177-186.e4. PubMed ID: 25445471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression of osteopontin and vascular endothelial growth factor in correlation with angiogenesis in monoclonal gammopathy of undetermined significance and multiple myeloma.
    Babarović E; Valković T; Budisavljević I; Balen I; Štifter S; Duletić-Načinović A; Lučin K; Jonjić N
    Pathol Res Pract; 2016 Jun; 212(6):509-16. PubMed ID: 26997492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of serum levels of selected biological parameters in monoclonal gammopathy of undetermined significance and multiple myeloma].
    Scudla V; Budíková M; Petrová P; Minarík J; Pika T; Bacovský J; Adamová D; Langová K;
    Klin Onkol; 2010; 23(3):171-81. PubMed ID: 20608327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interphase fluorescence in situ hybridization in multiple myeloma and monoclonal gammopathy of undetermined significance without and with positive plasma cell identification: analysis of 192 cases from the Region of Southern Denmark.
    Christensen JH; Abildgaard N; Plesner T; Nibe A; Nielsen O; Sørensen AG; Kerndrup GB;
    Cancer Genet Cytogenet; 2007 Apr; 174(2):89-99. PubMed ID: 17452249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between monoclonal gammopathy of undetermined significance and venous thromboembolic disease.
    Cohen AL; Sarid R
    Thromb Res; 2010 Mar; 125(3):216-9. PubMed ID: 19193398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Multiple myeloma after monoclonal gammopathy of uncertain significance. Study of 10 patients].
    Salgado C; Bladé J; López-Guillermo A; Cervantes F; Montserrat E; Rozman C
    Sangre (Barc); 1993 Oct; 38(5):371-4. PubMed ID: 8140498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Contribution of whole-body magnetic resonance in the diagnostics of monoclonal gammopathy of undetermined significance, multiple myeloma, and the assessment of Durie-Salmon Plus staging system].
    Scudla V; Herman M; Minarík J; Pika T; Hrbek J; Bacovský J; Heinzová V
    Vnitr Lek; 2011 Jan; 57(1):52-60. PubMed ID: 21351663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Monoclonal gammopathy of undetermined significance (MGUS) in Mexican mestizos: one institution's experience].
    Ruiz-Delgado GJ; Gómez Rangel JD
    Gac Med Mex; 2004; 140(4):375-9. PubMed ID: 15456147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.